Trial
NCT00465907
Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Lung Cancer
Intervention
Paclitaxel, Carboplatin and Irinotecan
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-11